Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Antipsychotic Stories

High Dose Antidepressant Offers Some Hope For Alzheimer's Patients
2014-02-19 12:58:56

Brett Smith for redOrbit.com - Your Universe Online Agitation is a common symptom in patients with Alzheimer's disease and is associated with severe adverse consequences for both patients and caregivers. According to a new study published in JAMA, a high dose of the antidepressant citalopram considerably reduced agitation in patients with Alzheimer’s. However, the drug administered at this dose was also associated with mild adverse cognitive and cardiac effects – a sign that this...

2014-02-12 12:32:22

NEW YORK, Feb. 12, 2014 /PRNewswire/ -- As Risperdal gynecomastia lawsuits (http://www.risperdallawsuitcenter.com/) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that the state of Ohio has launched an initiative to curb the overuse of antipsychotic drugs like Risperdal in children. The initiative is part of Ohio Minds Matter, an effort by the state to evaluate and improve prescribing of atypical antipsychotics and other psychotropic medications among...

2014-02-12 08:28:44

-- Eisai's Filing for Approval of BELVIQ as a Treatment for Chronic Weight Management Triggers $500,000 Milestone Payment to Arena -- SAN DIEGO, Feb. 12, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that Eisai Laboratorios Ltda., a subsidiary of Eisai Inc., has filed for marketing authorization of BELVIQ® as a treatment for chronic weight management with the Brazilian Health Surveillance Agency (Anvisa). In connection with the filing, Arena will receive a...

2014-02-11 16:25:38

First liquid formulation clozapine for treatment-resistant schizophrenia DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S. commercial availability of Versacloz(TM) (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder. "We are pleased to offer patients with...

2014-02-10 08:26:31

-- BELVIQ Now Covered by CVS Caremark -- SAN DIEGO, Calif., Feb. 10, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported that Eisai has secured improved patient access of BELVIQ(®) (lorcaserin HCl) with two leading healthcare benefit companies, and that the estimated number of insured commercial lives in the United States that have coverage for BELVIQ now exceeds 50 percent. CVS Caremark customers (employers and health plans) have broadened the coverage of...

2014-02-10 08:26:18

Number of Insured Commercial Lives in the U.S. with Coverage for BELVIQ® Now Exceeds 50 Percent WOODCLIFF LAKE, N.J., Feb. 10, 2014 /PRNewswire/ -- Eisai Inc. reported today that it has secured improved patient access of BELVIQ® (lorcaserin HCl) with two leading healthcare benefit companies: CVS Caremark and Aetna. CVS Caremark customers (employers and health plans) have broadened the coverage of Eisai's BELVIQ, according to Fingertip Formulary, an integrated database of formulary...

2014-02-08 23:01:40

Mental health watchdog, Citizens Commission on Human Rights recently celebrated its 45th Anniversary and Human Rights Awards Banquet in Los Angeles, California, honoring Detroit civil rights attorney, Allison Folmar, among other stellar individuals who have been fighting against abuse in the mental health industry. Detroit, Michigan (PRWEB) February 08, 2014 Citizens Commission on Human Rights (CCHR) celebrated its 45th Anniversary and Human Rights Awards Banquet on February 1st, in Los...

2014-02-07 23:01:26

The Firm is evaluating Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) February 07, 2014 With Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continuing to move forward in courts around the country, Bernstein Liebhard LLP notes the publication of yet another report detailing a rise in pediatric use of Risperdal and other...

2014-02-04 23:02:09

Wright & Schulte LLC is Investigating Risperdal Lawsuits on Behalf of Patients Who Used the Atypical Antipsychotic and Developed Gynecomastia, also Known as Male Breast Growth. Columbus, OH (PRWEB) February 04, 2014 Wright & Schulte LLC, an experienced law firm representing clients in Risperdal lawsuits, announces they have launched a new Facebook page to provide the public with the most up-to-date information regarding the ongoing litigation of Risperdal gynecomastia claims. The...

2014-02-04 12:28:45

NEW YORK, Feb. 4, 2014 /PRNewswire/ -- As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to move forward in U.S. courts, a new analysis out of Germany indicates that more children in that country are being treated with antipsychotic drugs. The analysis, which appeared last month in Deutsches Arzteblatt International, looked at data collected by a German health insurer, and found that the use of such medications among children and adolescents grew significantly...